Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Peking University Cancer Hospital & Institute
NGM Biopharmaceuticals, Inc
Jinling Hospital, China
Hospital Beatriz Ângelo
Samsung Medical Center
University Hospital, Essen
Suzhou Immunofoco Biotechnology Co., Ltd
Centre Hospitalier Universitaire Vaudois
Guangxi Medical University
Panolos Bioscience
Universitair Ziekenhuis Brussel
Shandong Provincial Hospital
Zhejiang University
University of Maia
Celon Pharma SA
Aurigene Discovery Technologies Limited
Henan Cancer Hospital
First People's Hospital of Hangzhou
Guangdong Provincial People's Hospital
RenJi Hospital
Hebei Medical University
Fujian Cancer Hospital
Chongqing Precision Biotech Co., Ltd
Kidney Cancer Research Bureau
RemeGen Co., Ltd.
RemeGen Co., Ltd.
National Cheng-Kung University Hospital
Icahn School of Medicine at Mount Sinai
Ajou University School of Medicine
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Tang-Du Hospital
Mario Negri Institute for Pharmacological Research
Base Therapeutics (Shanghai) Co., Ltd.
Massachusetts General Hospital
Hebei Medical University
Minneamrita Therapeutics LLC
Minneamrita Therapeutics LLC
Shanghai East Hospital
Fujian Medical University
Hebei Medical University
Jinling Hospital, China
Zhongnan Hospital
Rutgers, The State University of New Jersey
Queen Margaret University
Zhejiang Cancer Hospital
RenJi Hospital
RenJi Hospital
Sun Yat-sen University
Assaf-Harofeh Medical Center